TDA - Proprietary Screening Platform

Blue Sky's proprietary screening platform, Template-Directed Assembly™ (TDA2.0™) is a powerful technology for many membrane-associated proteins that enables development of assays in a more physiological environment than classical biochemical assays commonly in use today. Assays developed using TDA technology exhibit altered biochemical and pharmacological activity that more accurately reflects in vivo function. Therefore, early drug discovery programs that utilize TDA™ for membrane-associated therapeutic targets will yield molecules with better efficacy in in vitro and in vivo models and ultimately enable the development of more effective leads.

TDA2.0™ Overview